AstraZeneca: promising new data in oncology
(CercleFinance.com) - AstraZeneca will present new data on its portfolio and pipeline at the European Society for Medical Oncology (ESMO) Congress, from 20 to 24 October.
Nearly 100 abstracts will present 19 new approved and potential AstraZeneca drugs, including two late-breaking presidential symposia and 26 oral presentations.
Amongst these presentations, datopotamab deruxtecan will take centre stage, with promising data in lung and breast cancer.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Nearly 100 abstracts will present 19 new approved and potential AstraZeneca drugs, including two late-breaking presidential symposia and 26 oral presentations.
Amongst these presentations, datopotamab deruxtecan will take centre stage, with promising data in lung and breast cancer.
Copyright (c) 2023 CercleFinance.com. All rights reserved.